Bioprocessing
Gyros immunoassay integrated into TJU training programs
Immunoassay developer Gyros Protein Technologies announced on March 17 that it will integrate its technology into advanced training programs at the Jefferson Institute for Bioprocessing at Thomas Jefferson University (TJU).
New biocompatible microparticles created with heat, light
A new simple and scalable protein-processing technique based on temperature-sensitive phase changes creates unique microarchitectures within microparticles for use in drug delivery and other bioengineering applications, according to a study published in Nature Communications on March 12.  Discuss
National Postdoctoral Association cancels meeting due to COVID-19
Yet another scientific meeting has been canceled as a result of the rapidly spreading coronavirus disease (COVID-19) outbreak. On March 10, the National Postdoctoral Association made the decision to cancel its annual conference scheduled to take place in San Diego on March 27-29.
Berkeley Lights debuts new workflow for Opto CLD
Berkeley Lights has introduced Opto Cell Line Development (CLD) 2.0, a new workflow designed for the Beacon optofluidic instrument.
Major bioprocessing conference in Calif. postponed
The Bioprocess International West 2020 Conference has been postponed due to concerns about the coronavirus outbreak, which has resulted in the cancellation or postponement of medical and scientific meetings around the world.
Novasep creates new business unit
French life sciences service and technology provider Novasep has created a new Biopharma Solutions business unit to direct its activities in Belgium.
MilliporeSigma launches Lanexo software at Pittcon 2020
MilliporeSigma launched its Lanexo software for lab inventory, safety, and compliance management at the Pittcon meeting in Chicago on March 3. The new digital laboratory informatics software is designed to reduce time in labs and improve data quality and traceability.
Biopharma processing market shows early indicators of strong 2020
The biopharmaceutical processing market shows early indicators of strong 2020, according to our partners Strategic Directions International and Kalorama Information, which are developing an upcoming report on the sector.  Discuss
Thermo Fisher set to acquire Qiagen after all in $11.5B deal
After an on-and-off courtship, Thermo Fisher Scientific announced it is set to acquire Qiagen in a deal worth $11.5 billion. The transaction will give Thermo Fisher access to Qiagen's molecular diagnostics expertise and potentially lead to faster development of diagnostic tests.
Glia-to-neuron conversion gene therapy can treat Huntington's disease
Using adeno-associated virus technology, researchers have developed a novel gene therapy that can regenerate functional neurons in mouse models of Huntington's disease. The work was published in Nature Communications on February 27.  Discuss
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter